How to design a cell-based assay for drug screening + The drug discovery process: from the hit to the clinical candidate (8 h + 4 h)

This interdisciplinary course is targeted at students who wish to learn the basics and challenges of drug discovery and drug screening in information rich cell-based models. In the first part of the course (Grilli), aspects of assay design ranging from cell type choice, readout selection, standardization, miniaturization, high content analysis, will be covered. Moreover, advantages of targeted versus phenotypic assays in drug screening will be discussed. At the end, participants will be challenged in a competition to propose a cell-based assay that could be potentially relevant for their own research projects/interests. The second part of the course (Pirali) is devoted to providing PhD students engaged in the early drug discovery process with the concepts, the strategies and the methodologies that assist the identification of high-quality drug candidates. This is of utmost importance, as of the thousands of novel compounds that a drug discovery project leads to, only a fraction of these have sufficient ADMET properties to become a clinical candidate.


M. Grilli - T. Pirali


pharmacology, medicinal chemistry